Format
Sort by

Send to

Choose Destination

Selected items

Items: 20

1.

Is acanthosis nigricans a reliable indicator for risk of type 2 diabetes in obese children and adolescents? A systematic review.

Abraham C, Rozmus CL.

J Sch Nurs. 2012 Jun;28(3):195-205. doi: 10.1177/1059840511430952. Epub 2011 Dec 16. Review.

PMID:
22179051
3.

A study of pathogenesis of acanthosis nigricans and its clinical implications.

Puri N.

Indian J Dermatol. 2011 Nov;56(6):678-83. doi: 10.4103/0019-5154.91828.

4.

Acanthosis nigricans: a practical approach to evaluation and management.

Higgins SP, Freemark M, Prose NS.

Dermatol Online J. 2008 Sep 15;14(9):2. Review.

5.

Diagnosis and treatment of Acanthosis nigricans.

Kapoor S.

Skinmed. 2010 May-Jun;8(3):161-4; quiz 165. Review.

PMID:
21137622
6.

Alström syndrome with acanthosis nigricans: a case report and literature review.

Akdeniz N, Bilgili SG, Aktar S, Yuca S, Calka O, Kilic A, Kosem M.

Genet Couns. 2011;22(4):393-400. Review.

PMID:
22303800
7.

Treatment options in insulin resistance obesity-related acanthosis nigricans.

Romo A, Benavides S.

Ann Pharmacother. 2008 Jul;42(7):1090-4. doi: 10.1345/aph.1K446. Epub 2008 May 20.

PMID:
18492785
8.

Association of acanthosis nigricans and skin tags with insulin resistance.

Barbato MT, Criado PR, Silva AK, Averbeck E, Guerine MB, Sá NB.

An Bras Dermatol. 2012 Jan-Feb;87(1):97-104. Review.

9.

Acanthosis nigricans associated with insulin resistance : pathophysiology and management.

Hermanns-Lê T, Scheen A, Piérard GE.

Am J Clin Dermatol. 2004;5(3):199-203. Review.

PMID:
15186199
10.

Acanthosis nigricans in the setting of niacin therapy.

Hartman R, Defelice T, Tzu J, Meehan S, Sanchez M.

Dermatol Online J. 2011 Oct 15;17(10):11. Review.

12.

Acanthosis nigricans and insulin resistance in overweight children and adolescents.

Kluczynik CE, Mariz LS, Souza LC, Solano GB, Albuquerque FC, Medeiros CC.

An Bras Dermatol. 2012 Jul-Aug;87(4):531-7.

13.
14.

Using trichloroacetic acid in the treatment of acanthosis nigricans: a pilot study.

Zayed A, Sobhi RM, Abdel Halim DM.

J Dermatolog Treat. 2014 Jun;25(3):223-5. doi: 10.3109/09546634.2012.674194. Epub 2012 Jun 10.

PMID:
22494198
15.

Acanthosis nigricans as a paraneoplastic syndrome. Case reports and review of literature.

Krawczyk M, Mykała-Cieśla J, Kołodziej-Jaskuła A.

Pol Arch Med Wewn. 2009 Mar;119(3):180-3. Review.

16.

FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature.

Blomberg M, Jeppesen EM, Skovby F, Benfeldt E.

Dermatology. 2010;220(4):297-305. doi: 10.1159/000297575. Epub 2010 May 4. Review.

PMID:
20453470
17.

[Skin tags and Acanthosis nigricans: association with insulin resistance and overweight in Mexican children].

Valdés Rodríguez R, Moncada González B, Rivera Rodríguez SP, Aradillas García C, Hernández-Rodríguez H, Torres Álvarez B.

Gac Med Mex. 2011 Jul-Aug;147(4):297-302. Spanish.

PMID:
21894227
18.

Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices.

Kong AS, Williams RL, Smith M, Sussman AL, Skipper B, Hsi AC, Rhyne RL; RIOS Net Clinicians.

Ann Fam Med. 2007 May-Jun;5(3):202-8.

19.

Skin tag and acanthosis nigricans: do they have a predictive value for gestational diabetes mellitus?

Yılmaz E, Kelekci KH, Kelekci S.

Exp Clin Endocrinol Diabetes. 2011 Jul;119(7):419-22. doi: 10.1055/s-0030-1270478. Epub 2011 Apr 6.

PMID:
21472660
20.
Items per page

Supplemental Content

Write to the Help Desk